Energy
Genie Energy to Present at Sidoti December Small-Cap Virtual Investor Conference
Genie Energy to Present at Sidoti December Small-Cap Virtual Investor Conference PR Newswire NEWARK, N.J. , Dec. 1, 2022 /PRNewswire/ — Genie Energy Ltd., (NYSE: GNE, GNEPRA), a global provider of energy services, today announced that more...
Health
Agile Therapeutics To Present At The Upcoming RHK Capital Disruptive Growth Conference
PRINCETON, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it will participate in the RHK Capital Disruptive Growth Conference being held in the offices more...
Health
Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
Patent further strengthens Viveve’s novel dual-energy technology intellectual property portfolio as company plans for completion of pivotal PURSUIT clinical trial ENGLEWOOD, CO / ACCESSWIRE / December 1, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical more...
Biotech
Akari Therapeutics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference
NEW YORK and LONDON, Dec. 01, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the company will participate in the more...
Biotech
Cidara Therapeutics Announces Issuance of First U.S. Patent for CD388
Initial CD388 clinical data expected in the first half of 2023 SAN DIEGO, Dec. 01, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard more...
Biotech
Citius Pharmaceuticals, Inc. Announces U.S. Food and Drug Administration Acceptance of Biologics License Application of Denileukin Diftitox for the Treatment of Patients with Persistent or Recurrent Cutaneous T-Cell Lymphoma
Citius Pharmaceuticals, Inc. Announces U.S. Food and Drug Administration Acceptance of Biologics License Application of Denileukin Diftitox for the Treatment of Patients with Persistent or Recurrent Cutaneous T-Cell Lymphoma PR Newswire Prescription Drug User Fee more...
Cannabis
TILT Holdings Announces December Conference Schedule
PHOENIX, Dec. 01, 2022 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT ) (OTCQX: TLLTF ), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand more...
Energy
Enphase (ENPH) Introduces IQ8 Microinverters in Western Europe
Enphase Energy, Inc. ENPH launched its IQ8 microinverter in international markets by successfully introducing it in France and the Netherlands. Last year, the company made this product available to its customers in North America. By more...
Biotech
Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful completion of the previously announced tender offer (the “Offer”) to more...
Health
CENTOGENE to Participate in Upcoming Conferences in December
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 01, 2022 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its conference schedule more...